4892 — Cyfuse Biomedical KK Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapMomentum Trap

Annual balance sheet for Cyfuse Biomedical KK, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	2,073	2,413	4,437	3,874	3,053
Net Total Accounts Receivable
Net Total Receivables	37.2	57.7	69.8	49.8	64
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	2,152	2,559	4,565	3,987	3,240
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	32.9	27.3	189	170	142
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	2,196	2,646	4,815	4,215	3,518
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	207	386	683	666	649
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	647	746	1,046	1,011	976
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	1,549	1,900	3,770	3,203	2,542
Total Liabilities & Shareholders' Equity	2,196	2,646	4,815	4,215	3,518
Total Common Shares Outstanding